Intensity Therapeutics, Inc. filed its S-1/A on May 18, 2023 for the period ending Dec 31, 2022. In this report its auditor, EisnerAmper LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | +3.85% | -0.41% | -43.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.41% | 66.5M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- INTS Stock
- News Intensity Therapeutics, Inc.
- Intensity Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt